tiprankstipranks
Trending News
More News >
HABA Laboratories, Inc. (JP:4925)
:4925
Japanese Market

HABA Laboratories, Inc. (4925) Stock Statistics & Valuation Metrics

Compare
0 Followers

Total Valuation

HABA Laboratories, Inc. has a market cap or net worth of ¥6.23B. The enterprise value is ¥6.03B.
Market Cap¥6.23B
Enterprise Value¥6.03B

Share Statistics

HABA Laboratories, Inc. has 3,935,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding3,935,000
Owned by Insiders
Owned by Institutions

Financial Efficiency

HABA Laboratories, Inc.’s return on equity (ROE) is 0.06 and return on invested capital (ROIC) is 4.96%.
Return on Equity (ROE)0.06
Return on Assets (ROA)0.05
Return on Invested Capital (ROIC)4.96%
Return on Capital Employed (ROCE)0.06
Revenue Per Employee19.12M
Profits Per Employee913.73K
Employee Count631
Asset Turnover0.98
Inventory Turnover1.39

Valuation Ratios

The current PE Ratio of HABA Laboratories, Inc. is 11.41. HABA Laboratories, Inc.’s PEG ratio is -0.08.
PE Ratio11.41
PS Ratio0.00
PB Ratio0.82
Price to Fair Value0.74
Price to FCF-37.86
Price to Operating Cash Flow157.46
PEG Ratio-0.08

Income Statement

In the last 12 months, HABA Laboratories, Inc. had revenue of 12.06B and earned 576.57M in profits. Earnings per share was 152.47.
Revenue12.06B
Gross Profit7.99B
Operating Income589.51M
Pretax Income635.75M
Net Income576.57M
EBITDA811.56M
Earnings Per Share (EPS)152.47

Cash Flow

In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00

Dividends & Yields

HABA Laboratories, Inc. pays an annual dividend of ¥40, resulting in a dividend yield of 2.43%
Dividend Per Share¥40
Dividend Yield2.43%
Payout Ratio26.23%
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.26
52-Week Price Change-16.22%
50-Day Moving Average1.72K
200-Day Moving Average1.74K
Relative Strength Index (RSI)24.11
Average Volume (3m)973.00

Important Dates

HABA Laboratories, Inc. upcoming earnings date is Aug 14, 2025, TBA (Confirmed).
Last Earnings DateMay 9, 2025
Next Earnings DateAug 14, 2025
Ex-Dividend DateMar 28, 2025

Financial Position

HABA Laboratories, Inc. as a current ratio of 3.40, with Debt / Equity ratio of 18.87%
Current Ratio3.40
Quick Ratio2.30
Debt to Market Cap0.28
Net Debt to EBITDA-3.61
Interest Coverage Ratio34.63

Taxes

In the past 12 months, HABA Laboratories, Inc. has paid 59.18M in taxes.
Income Tax59.18M
Effective Tax Rate0.09

Enterprise Valuation

HABA Laboratories, Inc. EV to EBITDA ratio is 4.50, with an EV/FCF ratio of 2.46.
EV to Sales0.30
EV to EBITDA4.50
EV to Free Cash Flow2.46
EV to Operating Cash Flow2.25

Balance Sheet

HABA Laboratories, Inc. has ¥4.01B in cash and marketable securities with ¥2.11B in debt, giving a net cash position of -¥1.90B billion.
Cash & Marketable Securities¥4.01B
Total Debt¥2.11B
Net Cash-¥1.90B
Net Cash Per Share-¥483.10
Tangible Book Value Per Share¥2.36K

Margins

Gross margin is 67.86%, with operating margin of 4.89%, and net profit margin of 4.78%.
Gross Margin67.86%
Operating Margin4.89%
Pretax Margin5.27%
Net Profit Margin4.78%
EBITDA Margin6.73%
EBIT Margin5.41%

Analyst Forecast

The average price target for HABA Laboratories, Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast-2.13%
EPS Growth Forecast

Scores

Smart ScoreN/A
AI Score61
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis